geranylgeraniol has been researched along with Cirrhosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SQ; Fu, GS; Jiang, CY; Lv, X; Wang, MH; Ye, Y; Zhu, J | 1 |
1 other study(ies) available for geranylgeraniol and Cirrhosis
Article | Year |
---|---|
Alendronate prevents angiotensin II-induced collagen I production through geranylgeranylation-dependent RhoA/Rho kinase activation in cardiac fibroblasts.
Topics: Alendronate; Angiotensin II; Animals; Cells, Cultured; Collagen Type I; Depression, Chemical; Diterpenes; Dose-Response Relationship, Drug; Enzyme Activation; Fibroblasts; Fibrosis; Male; Molecular Targeted Therapy; Myocardium; Rats, Wistar; rho-Associated Kinases; Signal Transduction | 2015 |